UBS Group’s Science Strategic Acquisition Corp. Alpha Warrant SSAAW Stock Holding History

UBS Group’s Portfolio SSAAW Stock Details SSAAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,188	Closed	–	–	11724
2022 Q3	$0	Hold	3,188	–	–	﹤0.01%	11551
2022 Q2	$0	Buy	3,188 +2,800	+722%	+$470	﹤0.01%	11512
2022 Q1	$0	Buy	+388	New	+$161	﹤0.01%	11381
2021 Q4	–	Sell	-3,739	Closed	-$3K	–	11125
2021 Q3	$3K	Buy	3,739 +1,100	+42%	+$874	﹤0.01%	8894
2021 Q2	$2K	Buy	+2,639	New	+$1.99K	﹤0.01%	9054

UBS Group's SSAAW Position: Q4 2022 in Review

UBS Group sold out of Science Strategic Acquisition Corp. Alpha Warrant (SSAAW) in Q4 2022, closing a stake of 3,188 shares.

UBS Group first reported a position in SSAAW in Q2 2021 and held it in 5 quarters. The position peaked at $3K in Q3 2021. 0 funds tracked by Wall St. Rank hold SSAAW as of Q4 2022.

UBS Group reported no remaining Science Strategic Acquisition Corp. Alpha Warrant position as of Q4 2022 after selling out during the quarter.
UBS Group sold 3,188 Science Strategic Acquisition Corp. Alpha Warrant shares in Q4 2022.
UBS Group first reported a position in Science Strategic Acquisition Corp. Alpha Warrant in Q2 2021 and held it in 5 quarters.
UBS Group's Science Strategic Acquisition Corp. Alpha Warrant position peaked at $3K in Q3 2021.
0 funds tracked by Wall St. Rank held Science Strategic Acquisition Corp. Alpha Warrant as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.